Quantcast OCP Must Hold Briefings On Complex Pediatric NDA Supplements - Congoo
 
 
WORLD Log In
OCP Must Hold Briefings on Complex Pediatric NDA Supplements
Have an interest in this Story?
Sign Up for Real-Time email updates
FDA News  | November 05, 2009

Drugmakers who submit pediatric supplement NDAs with potentially complicated or controversial clinical pharmacology or biopharmaceutical issues should be aware that CDERâ??s Office of Clinical Pharmacology (OCP) is now required to hold briefings on them, according to a revised Manual of Policies and...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Gordon Kauer Gordon Kauer
Sales Rep/News/On Air
Broadcasting Industry
Martin P. Lee Martin P. Lee
Associate Lecturer
Knowledge Management

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.